Decline in Pathogenic Antibodies over Time in VITT

Germany, 4 November 2021, Schonborn et al, New England Journal of Medicine


A study involving 35 patients with serologically confirmed VITT (27 women and 8 men; median age, 53 years [range, 18 to 77 years]). The patients’ clinical symptoms started between days 5 and 18 after vaccination. All the patients presented with thrombocytopenia, and 30 presented with thrombosis.

Download PDF

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s